Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001659617-16-000001
Filing Date
2016-05-16
Accepted
2016-05-16 17:03:20
Documents
1
Effectiveness Date
2016-05-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5736
  Complete submission text file 0001659617-16-000001.txt   6866
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-263286 | Film No.: 161654920
SIC: 2834 Pharmaceutical Preparations